
Wuhan Keqian Biology Co Ltd
SSE:688526

Wall Street
Price Targets
Price Targets Summary
Wuhan Keqian Biology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Wuhan Keqian Biology Co Ltd
is 22.06 CNY
with a low forecast of 20.2 CNY and a high forecast of 24.41 CNY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Wuhan Keqian Biology Co Ltd
For the last 6 years the
compound annual growth rate for
Wuhan Keqian Biology Co Ltd's operating income is
-4%.
The projected
CAGR
for the next 2 years is
31%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Wuhan Keqian Biology Co Ltd's stock price target?
Price Target
22.06
CNY
According to Wall Street analysts, the average 1-year price target for
Wuhan Keqian Biology Co Ltd
is 22.06 CNY
with a low forecast of 20.2 CNY and a high forecast of 24.41 CNY.
What is Wuhan Keqian Biology Co Ltd's Revenue forecast?
Projected CAGR
15%
For the last 6 years the
compound annual growth rate for
Wuhan Keqian Biology Co Ltd's revenue is
4%.
The projected
CAGR
for the next 3 years is
15%.
What is Wuhan Keqian Biology Co Ltd's Operating Income forecast?
Projected CAGR
31%
For the last 6 years the
compound annual growth rate for
Wuhan Keqian Biology Co Ltd's operating income is
-4%.
The projected
CAGR
for the next 2 years is
31%.
What is Wuhan Keqian Biology Co Ltd's Net Income forecast?
Projected CAGR
14%
For the last 6 years the
compound annual growth rate for
Wuhan Keqian Biology Co Ltd's net income is
0%.
The projected
CAGR
for the next 2 years is
14%.